Two observational studies indicate GLP-1 receptor agonists may reduce complications after transcatheter aortic valve replacement (TAVR) and carotid artery stenting (CAS). Post-TAVR tirzepatide use was ...
A risk model allowing cardiologists and their patients to share decision-making about undergoing surgery after transcatheter aortic valve replacement (TAVR) had received high marks for its accuracy in ...
CHICAGO — Five years after treatment, patients with severe aortic stenosis had comparable rates of all-cause mortality or disabling stroke, whether they received transcatheter aortic valve replacement ...
The UHS Heart & Vascular Institute recently celebrated a significant milestone with the completion of their 1,000th TAVR (Transcatheter Aortic Valve Replacement) procedure. This achievement is more ...
WASHINGTON -- Beyond bleeding alone, a regimen of dual antiplatelet therapy (DAPT) after transcatheter aortic valve replacement (TAVR) was associated with excess mortality, based on observational data ...
LONDON -- It was best that people interrupt their oral anticoagulation (OAC) therapy around the time they get transcatheter aortic valve replacement (TAVR, also TAVI), the POPular PAUSE TAVI trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results